Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Review

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review.

Phillips KA, Veenstra DL, Oren E, et al. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA. 2001;286(18):2270-9.

Save
Print
February 9, 2011
Phillips KA, Veenstra DL, Oren E, et al. JAMA. 2001;286(18):2270-9.
View more articles from the same authors.

This study suggests that utilizing a patient’s genetic information to individualize medication treatments can help reduce adverse drug reactions.

Save
Print
Cite
Citation

Phillips KA, Veenstra DL, Oren E, et al. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA. 2001;286(18):2270-9.